Telix Pharmaceuticals delivers first commercial doses from Belgian manufacturing hub

Innovent presents mazdutide Phase 3 clinical study results at ADA 85th Scientific Sessions

Hoth Therapeutics reports positive interim results for HT-001 topical therapy

Aiforia Technologies launches CE-IVD marked AI solution for breast cancer diagnostics

Stockholders approve proposed merger of TuHURA Biosciences and Kineta

Sarclisa recommended for EU approval in newly diagnosed transplant-eligible multiple myeloma

Harbour BioMed and Otsuka collaborate on advancing BCMAxCD3 bispecific T-cell engagers

Dizal completes enrolment in sunvozertinib vs. platinum doublet phase III study

RyboDyn joins Lilly Gateway Labs' innovation hub

GRAIL reports positive results from Galleri multi-cancer early detection test registrational study

Hoth Therapeutics regains Nasdaq compliance

LOTTE BIOLOGICS and Ottimo Pharma sign antibody manufacturing contract

Simcere Zaiming reports first patient dosed in SIM0500 US Phase 1 trial in patients with relapsed/refractory multiple myeloma

IMUNON unveils promising Phase 2 translational data for IMNN-001 in advanced ovarian cancer

MAIA Biotechnology signs master clinical supply agreement with Roche to advance combination cancer therapies